DM
AMAG

Delphi Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Delphi Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10,859
Closed -$328K – 107
2015
Q4 		$328K Sell
10,859
-120,381
-92% -$3.89M 0.21% 93
2015
Q3 		$5.21M Buy
+131,240
New +$8.15M 0.82% 70

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIM
Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return

Delphi Management's AMAG Position: Q1 2016 in Review

Delphi Management sold out of AMAG Pharmaceuticals (AMAG) in Q1 2016, closing a stake of 10,859 shares — an estimated $328K sold.

Delphi Management first reported a position in AMAG in Q3 2015 and held it in 2 quarters. The position peaked at $5.21M in Q3 2015. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2016.

  • Delphi Management reported no remaining AMAG Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Delphi Management sold 10,859 AMAG Pharmaceuticals shares in Q1 2016, an estimated $328K.
  • Delphi Management first reported a position in AMAG Pharmaceuticals in Q3 2015 and held it in 2 quarters.
  • Delphi Management's AMAG Pharmaceuticals position peaked at $5.21M in Q3 2015.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2016.

Based on Delphi Management's 13F filing for Q1 2016, filed 13 May 2016.